C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 9/68 (2006.01) C12N 5/10 (2006.01) C12N 15/57 (2006.01)
Patent
CA 2563675
Polynucleotides and polypeptides relating to a recombinantly-modified plasmin(ogen) molecule are provided. The plasmin(ogen) molecule has a single kringle domain N-terminal to the activation site present in the native human plasminogen molecule, and exhibits lysine-binding and significant enzymatic characteristics associated with the native enzyme.
L'invention concerne des polynucléotides et des polypeptides relatifs à une molécule de plasmine (plasminogène) à modification par recombinaison. Ladite molécule comporte une terminaison N de domaine kringle unique sur le site d'activation présent dans la molécule plasminogène humaine d'origine et présente des propriétés de liaison avec la lysine et des caractéristiques enzymatiques importantes associées à l'enzyme d'origine.
Hunt Jennifer Audrey
Novokhatny Valery
Borden Ladner Gervais Llp
Talecris Biotherapeutics Inc.
LandOfFree
Recombinantly modified plasmin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinantly modified plasmin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinantly modified plasmin will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1379926